Expensify Announces Q1 2026 Results
Interchange revenue derived from the
A Message From Our Founder
In Q1 2026,
Product development remained strong, with more than 30 improvements shipped during the quarter across Home, Insights, Concierge, card controls, expense automation, reporting, and mobile receipt management, including merchant rules, GPS mileage tracking, enhanced analytics, virtual card controls, and expanded accountant workflows. Together with continued Expensify Card interchange growth, positive free cash flow, and an increase in
-david
Founder and CEO of
Financial
First Quarter 2026 Highlights
-
Revenue, net was
$34.0 million , a decrease of 6% compared to the same period last year. -
Generated
$0.1 million of cash from operating activities. -
Free cash flow was
$2.5 million , which includes a$2.6 million one time payment related to settling the shareholder class action lawsuit. -
Net loss was
$2.3 million , compared to$3.2 million for the same period last year. -
Non-GAAP net income was
$3.6 million . -
Adjusted EBITDA was
$6.2 million . -
Interchange revenue derived from the Expensify Card grew to
$5.5 million , an increase of 10% compared to the same period last year. -
See Financial Outlook section for Free Cash Flow guidance for fiscal year ending
December 31, 2026 .
Business
First Quarter 2026 Highlights
- Paid members - Paid members were 632,000, a decrease of 4% from the same period last year.
-
Partnerships - The company launched integrations with Campfire ERP, Rillet ERP, and
American Airlines ; the company announced strategic partnerships with Xero, ANZ Bank,Kiwi Bank , and theInstitute of Commercial Payments . - Product improvements - The company released over 30 product improvements in Q1, highlighted by merchant level rules, an action driven homepage, and powerful new insights.
Financial Outlook
Free Cash Flow
The Company does not provide a reconciliation for free cash flow estimates on a forward-looking basis because it is unable, without making unreasonable efforts, to provide a meaningful or reasonably accurate calculation or estimation of net cash provided by operating activities and certain reconciling items on a forward-looking basis, which could be significant to the Company's results.
Stock Based Compensation
An estimate of expected stock-based compensation for the next four fiscal quarters is as follows, which is driven primarily by the pre-IPO grant of RSUs issued to all employees (which vest quarterly over eight years with approximately three years remaining).
Est. stock-based compensation (millions)
|
|
Q2 2026 |
|
Q3 2026 |
|
Q4 2026 |
|
Q1 2027 |
||||||||||||||||
|
|
Low |
|
High |
|
Low |
|
High |
|
Low |
|
High |
|
Low |
|
High |
||||||||
|
Cost of revenue, net |
$ |
1.8 |
|
$ |
2.6 |
|
$ |
1.7 |
|
$ |
2.5 |
|
$ |
1.7 |
|
$ |
2.5 |
|
$ |
1.7 |
|
$ |
2.5 |
|
Research and development |
|
1.5 |
|
|
2.1 |
|
|
1.4 |
|
|
2.0 |
|
|
1.4 |
|
|
2.0 |
|
|
1.3 |
|
|
1.9 |
|
General and administrative |
|
0.8 |
|
|
1.2 |
|
|
0.8 |
|
|
1.2 |
|
|
0.8 |
|
|
1.2 |
|
|
0.7 |
|
|
1.1 |
|
Sales and marketing |
|
0.6 |
|
|
0.8 |
|
|
0.6 |
|
|
0.8 |
|
|
0.6 |
|
|
0.8 |
|
|
0.6 |
|
|
0.8 |
|
Total |
$ |
4.7 |
|
$ |
6.7 |
|
$ |
4.5 |
|
$ |
6.5 |
|
$ |
4.5 |
|
$ |
6.5 |
|
$ |
4.3 |
|
$ |
6.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
Availability of Information on Expensify’s Website
Investors and others should note that
Conference Call
Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with
We believe our non-GAAP financial measures are useful in evaluating our business, measuring our performance, identifying trends affecting our business, formulating business plans and making strategic decisions. Accordingly, we believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team. These non-GAAP financial measures are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled metrics or measures presented by other companies. Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business. A reconciliation of each non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP is at the end of this press release.
Adjusted EBITDA. We define adjusted EBITDA as net loss excluding provision for income taxes, other income, net, depreciation and amortization, and stock-based compensation expense.
Non-GAAP net income. We define non-GAAP net income as net loss excluding stock-based compensation expense.
Free cash flow. We define free cash flow as net cash provided by operating activities excluding changes in settlement assets, net and settlement liabilities, reduced by the purchases of property and equipment and software development costs.
The tables at the end of the Condensed Consolidated Financial Statements provide reconciliations to the most directly comparable GAAP financial measure to each of these non-GAAP financial measures.
Forward-Looking Statements
Forward-looking statements in this press release, or made during the earnings call, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1955. These statements include statements regarding our strategy, future financial condition, future operations, future cash flow, projected costs, prospects, plans, objectives of management and expected market growth, product developments and their potential impact and our stock-based compensation estimates and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “shall,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “goal,” “ambition,” “objective,” “seeks,” “outlook,” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: the impact on inflation on us and our members; our borrowing costs, which have and may continue to increase as a result of increases in interest rates; our expectations regarding our financial performance and future operating performance; our ability to attract and retain members, expand usage of our platform, sell subscriptions to our platform and convert individuals and organizations into paying customers; the timing and success of new features, integrations, capabilities and enhancements by us, or by competitors to their products, or any other changes in the competitive landscape of our market; the amount and timing of operating expenses and capital expenditures that we may incur to maintain and expand our business and operations to remain competitive; the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; our ability to make required payments under and to comply with the various requirements of our current and future indebtedness; our cash flows, the prevailing stock prices, general economic and market conditions and other considerations that could affect the specific timing, price and size of repurchases under our stock repurchase program or our ability to fund any stock repurchases; geopolitical tensions, including the war in
About
|
Condensed Consolidated Balance Sheets (unaudited, in thousands, except share and per share data) |
|||||||
|
|
As of
|
|
As of
|
||||
|
|
|
2026 |
|
|
|
2025 |
|
|
Assets |
|
|
|
||||
|
Cash and cash equivalents |
$ |
66,528 |
|
|
$ |
63,080 |
|
|
Accounts receivable, net |
|
12,115 |
|
|
|
12,617 |
|
|
Settlement assets, net |
|
53,581 |
|
|
|
45,378 |
|
|
Prepaid expenses |
|
4,792 |
|
|
|
5,588 |
|
|
Other current assets |
|
21,205 |
|
|
|
26,344 |
|
|
Total current assets |
|
158,221 |
|
|
|
153,007 |
|
|
Capitalized software, net |
|
13,269 |
|
|
|
13,596 |
|
|
Property and equipment, net |
|
12,861 |
|
|
|
13,016 |
|
|
Lease right-of-use assets |
|
4,559 |
|
|
|
4,730 |
|
|
Deferred tax assets, net |
|
486 |
|
|
|
494 |
|
|
Other assets |
|
1,201 |
|
|
|
1,146 |
|
|
Total assets |
$ |
190,597 |
|
|
$ |
185,989 |
|
|
Liabilities and stockholders' equity |
|
|
|
||||
|
Accounts payable |
$ |
938 |
|
|
$ |
289 |
|
|
Accrued expenses and other liabilities |
|
7,668 |
|
|
|
17,893 |
|
|
Lease liabilities, current |
|
648 |
|
|
|
678 |
|
|
Settlement liabilities |
|
36,083 |
|
|
|
27,545 |
|
|
Total current liabilities |
|
45,337 |
|
|
|
46,405 |
|
|
Lease liabilities, non-current |
|
4,910 |
|
|
|
5,061 |
|
|
Other liabilities |
|
1,822 |
|
|
|
1,778 |
|
|
Total liabilities |
|
52,069 |
|
|
|
53,244 |
|
|
Commitments and contingencies |
|
|
|
||||
|
Stockholders' equity: |
|
|
|
||||
|
Preferred stock, par value |
|
— |
|
|
|
— |
|
|
Common stock, par value
Class A common stock; 1,000,000,000 shares authorized; 84,272,879 and 80,767,385 shares issued and outstanding as of
LT10 common stock; 21,871,197 shares authorized; 4,209,827 shares issued and outstanding as of
LT50 common stock; 24,893,067 and 24,967,114 shares authorized as of |
|
10 |
|
|
|
9 |
|
|
Additional paid-in capital |
|
313,072 |
|
|
|
304,953 |
|
|
Accumulated deficit |
|
(174,554 |
) |
|
|
(172,217 |
) |
|
Total stockholders' equity |
|
138,528 |
|
|
|
132,745 |
|
|
Total liabilities and stockholders' equity |
$ |
190,597 |
|
|
$ |
185,989 |
|
|
|
|
|
|
||||
|
Condensed Consolidated Statements of Operations (unaudited, in thousands, except share and per share data) |
|||||||
|
|
Three Months Ended |
||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
Revenue, net |
$ |
33,969 |
|
|
$ |
36,074 |
|
|
Cost of revenue, net(1) |
|
17,798 |
|
|
|
17,832 |
|
|
Gross margin |
|
16,171 |
|
|
|
18,242 |
|
|
Operating expenses: |
|
|
|
||||
|
Research and development(1) |
|
5,265 |
|
|
|
5,358 |
|
|
General and administrative(1) |
|
9,118 |
|
|
|
10,829 |
|
|
Sales and marketing(1) |
|
3,760 |
|
|
|
3,542 |
|
|
Total operating expenses |
|
18,143 |
|
|
|
19,729 |
|
|
Loss from operations |
|
(1,972 |
) |
|
|
(1,487 |
) |
|
Other income, net |
|
171 |
|
|
|
324 |
|
|
Loss before income taxes |
|
(1,801 |
) |
|
|
(1,163 |
) |
|
Provision for income taxes |
|
(536 |
) |
|
|
(2,006 |
) |
|
Net loss |
$ |
(2,337 |
) |
|
$ |
(3,169 |
) |
|
Net loss per share: |
|
|
|
||||
|
Basic and diluted |
$ |
(0.02 |
) |
|
$ |
(0.03 |
) |
|
Weighted average shares of common stock used to compute net loss per share: |
|
|
|
||||
|
Basic and diluted |
|
93,719,202 |
|
|
|
91,501,083 |
|
|
|
|
|
|
||||
|
(1) Includes stock-based compensation expense as follows: |
|||||
|
|
Three Months Ended |
||||
|
|
2026 |
|
2025 |
||
|
Cost of revenue, net |
$ |
2,311 |
|
$ |
3,039 |
|
Research and development |
|
1,863 |
|
|
2,402 |
|
General and administrative |
|
1,035 |
|
|
1,572 |
|
Sales and marketing |
|
768 |
|
|
977 |
|
Total stock-based compensation expense |
$ |
5,977 |
|
$ |
7,990 |
|
|
|
|
|
||
|
Condensed Consolidated Statements of Cash Flows (unaudited, in thousands) |
|||||||
|
|
Three Months Ended |
||||||
|
|
|
2026 |
|
|
|
2025 |
|
|
Cash flows from operating activities: |
|
|
|
||||
|
Net loss |
$ |
(2,337 |
) |
|
$ |
(3,169 |
) |
|
Adjustments to reconcile net loss to cash provided by operating activities: |
|
|
|
||||
|
Depreciation and amortization |
|
2,256 |
|
|
|
1,983 |
|
|
Reduction of operating lease right-of-use assets |
|
137 |
|
|
|
138 |
|
|
Loss on impairment, receivables and sale or disposal of equipment |
|
544 |
|
|
|
156 |
|
|
Stock-based compensation |
|
5,977 |
|
|
|
7,990 |
|
|
Amortization of debt issuance costs |
|
52 |
|
|
|
11 |
|
|
Deferred tax assets |
|
8 |
|
|
|
(6 |
) |
|
Changes in assets and liabilities: |
|
|
|
||||
|
Accounts receivable, net |
|
(28 |
) |
|
|
53 |
|
|
Settlement assets, net |
|
(4,481 |
) |
|
|
(5,555 |
) |
|
Prepaid expenses |
|
796 |
|
|
|
590 |
|
|
Other current assets |
|
6,261 |
|
|
|
150 |
|
|
Other assets |
|
(55 |
) |
|
|
(26 |
) |
|
Accounts payable |
|
547 |
|
|
|
330 |
|
|
Accrued expenses and other liabilities |
|
(10,189 |
) |
|
|
1,462 |
|
|
Operating lease liabilities |
|
(144 |
) |
|
|
(137 |
) |
|
Settlement liabilities |
|
730 |
|
|
|
3,809 |
|
|
Other liabilities |
|
44 |
|
|
|
77 |
|
|
Net cash provided by operating activities |
|
118 |
|
|
|
7,856 |
|
|
Cash flows from investing activities: |
|
|
|
||||
|
Software development costs |
|
(1,412 |
) |
|
|
(498 |
) |
|
Net cash used in investing activities |
|
(1,412 |
) |
|
|
(498 |
) |
|
Cash flows from financing activities: |
|
|
|
||||
|
Change in customer funds, net |
|
4,437 |
|
|
|
(3,051 |
) |
|
Principal payments of finance leases |
|
(37 |
) |
|
|
(34 |
) |
|
Proceeds from common stock purchased under Matching Plan |
|
1,828 |
|
|
|
1,151 |
|
|
Proceeds from issuance of common stock on exercise of stock options |
|
39 |
|
|
|
91 |
|
|
Net cash provided by (used in) financing activities |
|
6,267 |
|
|
|
(1,843 |
) |
|
Net increase in cash and cash equivalents and restricted cash |
|
4,973 |
|
|
|
5,515 |
|
|
Cash and cash equivalents and restricted cash, beginning of period |
|
104,624 |
|
|
|
90,834 |
|
|
Cash and cash equivalents and restricted cash, end of period |
$ |
109,597 |
|
|
$ |
96,349 |
|
|
Noncash investing and financing items: |
|
|
|
||||
|
Stock-based compensation capitalized as software development costs |
$ |
271 |
|
|
$ |
239 |
|
|
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses |
$ |
182 |
|
|
$ |
174 |
|
|
Fair value of common stock issued to settle liability-classified restricted stock units |
$ |
376 |
|
|
$ |
— |
|
|
Reconciliation of cash and cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
66,528 |
|
|
$ |
59,627 |
|
|
Restricted cash included in other current assets |
|
19,718 |
|
|
|
19,225 |
|
|
Restricted cash included in settlement assets, net |
|
23,351 |
|
|
|
17,497 |
|
|
Total cash and cash equivalents and restricted cash |
$ |
109,597 |
|
|
$ |
96,349 |
|
|
|
|
|
|
||||
|
Reconciliation of GAAP to Non-GAAP Financial Measures (unaudited, in thousands, except percentages) |
|||||||
|
Adjusted EBITDA and Adjusted EBITDA Margin |
|||||||
|
|
Three Months Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Net loss |
$ |
(2,337 |
) |
|
$ |
(3,169 |
) |
|
Net loss margin |
|
(7 |
)% |
|
|
(9 |
)% |
|
Add: |
|
|
|
||||
|
Provision for income taxes |
|
536 |
|
|
|
2,006 |
|
|
Other income, net |
|
(171 |
) |
|
|
(324 |
) |
|
Depreciation and amortization |
|
2,215 |
|
|
|
1,943 |
|
|
Stock-based compensation expense |
|
5,977 |
|
|
|
7,990 |
|
|
Adjusted EBITDA |
$ |
6,220 |
|
|
$ |
8,446 |
|
|
Adjusted EBITDA margin |
|
18 |
% |
|
|
23 |
% |
|
|
|
|
|
||||
|
Non-GAAP Net Income and Non-GAAP Net Income Margin |
|||||||
|
|
Three Months Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Net loss |
$ |
(2,337 |
) |
|
$ |
(3,169 |
) |
|
Net loss margin |
|
(7 |
)% |
|
|
(9 |
)% |
|
Add: |
|
|
|
||||
|
Stock-based compensation expense |
|
5,977 |
|
|
|
7,990 |
|
|
Non-GAAP net income |
$ |
3,640 |
|
|
$ |
4,821 |
|
|
Non-GAAP net income margin |
|
11 |
% |
|
|
13 |
% |
|
|
|
|
|
||||
|
Free Cash Flow and Free Cash Flow Margin |
|||||||
|
|
Three Months Ended |
||||||
|
|
2026 |
|
2025 |
||||
|
Net cash provided by operating activities |
$ |
118 |
|
|
$ |
7,856 |
|
|
Operating cash flow margin |
|
— |
% |
|
|
22 |
% |
|
Changes in settlement assets and liabilities: |
|
|
|
||||
|
Settlement assets, net |
|
4,481 |
|
|
|
5,555 |
|
|
Settlement liabilities |
|
(730 |
) |
|
|
(3,809 |
) |
|
Less: |
|
|
|
||||
|
Software development costs |
|
(1,412 |
) |
|
|
(498 |
) |
|
Free cash flow |
$ |
2,457 |
|
|
$ |
9,104 |
|
|
Free cash flow margin |
|
7 |
% |
|
|
25 |
% |
|
|
|
|
|
||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260507810102/en/
Investor Relations Contact
investors@expensify.com
Press Contact
press@expensify.com
Source: